Case reports |






* Fifth Department of Internal Medicine;
Department of Infectious Diseases;
Department of Pathology;
Department of Hematology, Evaggelismos Hospital, Athens, Greece;
** Department of Hematology, Oncology and Blood and Marrow Transplantation, University of Kentucky, Lexington, KY, USA
Correspondence to: Dr E Mylona, MD, Fifth Department of Internal Medicine, Evaggelismos Hospital, 45-47 Hipsilantou Street, Kolonaki, GR-106 76 Athens, Greece Email: emylon{at}med.uoa.gr
Primary effusion lymphoma (PEL) is a unique form of non-Hodgkin lymphoma, mainly met in severely immunocompromised, HIV-positive patients. PEL is aetiologically related to human herpes virus-8 (HHV-8) and it usually presents as a lymphomatous body cavity effusion in the absence of a solid tumour mass. Recently, cases of HIV-positive patients with HHV-8-positive solid tissue lymphomas, not associated with an effusion, have been reported (solid variant of PEL). The prognosis of PEL is reported to be poor. We report a case of an HIV-positive patient with a typical solid variant of PEL without effusion. Interestingly, his disease developed while being on stable antiretroviral therapy (ART) with high CD4 counts. He had a relatively long survival with chemotherapy and ART.
Key Words: primary effusion lymphoma HIV HHV-8 non-Hodgkin lymphoma solid variant of primary effusion lymphoma
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?